Increase in Convenience, Effective Upgrades in Home Diagnostics Boost Global Market Growth

The healthcare industry is constantly seeking to address patients’ unmet well-being needs for a variety of acute and chronic diseases. Concurrently, governments are attempting to keep healthcare spending sustainable, while granting equal access to high-quality care. With the rising prevalence of several diseases, the home diagnostics market is trending for its convenience for the patient as well as hospital facilities. Some diagnostic tools provide clinicians with the ability to collect important data points remotely. Health data that can be gathered via home testing includes blood pressure, pulmonary testing, dermatological diagnosis, and neurological testing. With easy access to healthcare at doorsteps, the global home diagnostics market is anticipated to rise during the forecast period.

Diagnostics deliver information that can benefit patients by enabling the adoption of the right treatment, helping health experts to choose relevant preventive interventions and giving vital prognostic data that can optimize care pathways and administration. However, home diagnostics has a varied history. It was initially developed to offer patients sensitive testing in the secrecy of their own homes. The field has expanded greatly since the first at-home pregnancy tests became available in the 1970s. Presently, highly customized home collection kits allow patients to collect and submit their biological samples directly for laboratory testing, eliminating the need for clinicians to manage the preparation, packaging, and shipping of samples.

Request a sample to get extensive insights into the Home Diagnostics Market

COVID-19 Pandemic Proves Propitious for Home-Based Diagnostic Services

The COVID-19 pandemic has restricted people to their homes, restraining travel and non-essential outdoor activities for months. However, with the implementation of lockdowns in several countries, people are sheltering at homes, which is increasing the demand for home diagnostic services. Moreover, people are now hesitant to visit hospitals, clinics, and pathology labs for diagnostics tests due to the fear of the pandemic spreading in such places. As a result, the demand for home-based diagnostics, medical check-ups, and lab tests has increased considerably since the outbreak. As COVID-19 necessitates a remote approach to clinical research, clinical trial managers and clinical service providers must work together to manage the fast-changing needs of the trial landscape.

As more people were forced to stay at home, the need for more home diagnostic services has increased rapidly. The need has always been there, as many vulnerable patients existed even before the coronavirus outbreak. However, the numbers were smaller. With the pandemic of this scale, many people are realizing the benefits of home diagnostics, which is driving the home diagnostics market. In addition, as the number of diseases will still exist after the post-pandemic period, the demand for the home diagnostics market is anticipated to grow during the forecast period.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Technological Advancements in Healthcare Sector Improve Efficiency of Remote Diagnostics

During the previous years, the market has encountered a slew of investments by various start-up companies and businesses seeking to introduce innovative technological advancements, indicating extensive research and development initiatives. Besides, the home diagnostics market endured credible incentives from the COVID-19 pandemic, as a standard shift toward preventive healthcare was witnessed. The declining footfall in hospitals amid the fear of potential COVID-19 infection has compelled patients with chronic ailments to seek home-based treatment. In addition, producers are effectively leveraging technological advancements by introducing smart solutions, including Big Data analytics, artificial intelligence, and cloud computing for data assimilation and disbursement of treatment, leading to significant disruptions in the landscape.

Regionally, due to the increasing prevalence of various lifestyle-associated and infectious diseases such as obesity, diabetes, cancer, and STDs in North America, the region is most likely to hold a prominent share of the global home diagnostics market.

Moreover, rising consumer awareness in Europe and enhancing lifestyles are projecting the regional market to grow at a high CAGR during the forecast period. Overall, the global home diagnostics market is projected to expand at a CAGR of 4.4% from 2021 to 2031.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Home Diagnostics Market

Analysts’ Viewpoint

Businesses are discovering lucrative development potential across emerging markets, particularly in Asia. India is anticipated to yield immense development opportunities, given the exponential population growth experienced in the past few years. The global home diagnostics market is observing a high growth rate and expected to continue to expand in the near future due to the rising disposable income of people across nations, which enable them to afford products for self-care.

Home Diagnostics Market: Overview

  • This report analyzes the current scenario and future prospects of the global home diagnostics market. Rise in demand for early disease detection and diagnosis; availability of personalized medicines; growth in prevalence of various lifestyle-associated and infectious diseases; and increase in geriatric population are key factors projected to propel the global market home diagnostics market during the forecast period.
  • The report includes an elaborate executive summary, which provides a snapshot of various segments of the global home diagnostics market. It also provides information and data analysis of the home diagnostics market based on type, sample type, distribution channel, and region.
  • The overview section of the report provides a detailed qualitative analysis of drivers, restraints, and opportunities that affect the global home diagnostics market
  • The report includes company profiles, which provide information about their business, product portfolios, and competitive landscape in the global home diagnostics market
  • The report on the home diagnostics market offers market attractiveness analysis of regions and segments
  • The last section of the report comprises quantitative and qualitative analysis of market share/position of key players operating in the global home diagnostics market. It analyzes key competitive strategies adopted by major industry players, thereby presenting a thorough understanding of the competitive scenario in the global home diagnostics market.

Home Diagnostics Market: Key Segments

  • In terms of sample type, the global home diagnostics market has been classified into blood, urine and others. The blood sample type segment is projected to account for major share of the home diagnostics market in the near future. The segment’s dominance can be ascribed to increase in the number of glucose monitoring device companies offering blood-based test kits. Technological advancements such as smart home diagnostics kits has also boosted the growth of the market.
  • Based on type, the global home diagnostics market has been categorized into glucose monitoring, cholesterol detection, pregnancy, allergies & intolerances, infectious disease testing, fertility, ovulation & sexual health, and drug abuse testing. The glucose monitoring segment dominated the home diagnostics market in 2020. Number of users of infectious disease testing has increased at a rapid pace. After the outbreak of the global pandemic, there is huge surge in the demand for at-home diagnostics for the COVID-19, which is a type of infectious disease. The number of people interested in knowing any other type of infectious diseases has also increased. This is anticipated to drive the demand for infectious diseases testing, especially in developed countries across the globe.
  • In terms of distribution channel, the global home diagnostics market has been classified into retail, online, and others. The retail segment is projected to account for a major share of the home diagnostics market during the forecast period. Rise in the number of public-private partnerships is expected to drive the segment during of the global home diagnostics market during the forecast period.
  • Market size and forecast for each of these segments have been provided from 2017 to 2031. The CAGR of respective segments has also been provided from 2021 to 2031, considering 2020 as the base year.

Home Diagnostics Market: Regional Outlook

  • In terms of region, the global home diagnostics market has been split into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, Switzerland, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). Each region considered in the market has been divided into countries/sub-regions.
  • The home diagnostics market report provides size and forecast for each region and country/sub-region from 2017 to 2031. The CAGR for each of these regions and countries has also been provided for the forecast period from 2021 to 2031. The home diagnostics market study also covers the competitive scenario across the globe.

Companies Covered in Home Diagnostics Market Report

  • Key players operating in the global home diagnostics market have been profiled based on attributes such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies
  • Major companies profiled in the home diagnostics market report are
    • SelfDiagnostics
    • F. Hoffmann-La Roche Ltd.
    • Trinity Biotech Plc
    • Bionime Corporation
    • ARKRAY, Inc.
    • ACON Laboratories, Inc.
    • Assure Tech.(Hangzhou) Co., LTD.
    • Abbott
    • Becton Dickinson & Company
    • Quidel Corporation

Home Diagnostics Market – Segmentation

Type
  • Glucose Monitoring
  • Cholesterol Detection
  • Pregnancy
  • Allergies & Intolerances
  • Infectious Disease Testing
  • Fertility, Ovulation & Sexual Health
  • Drug Abuse Testing
Sample Type
  • Blood
  • Urine
  • Others
Distribution Channel
  • Retail
  • Online
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

The global home diagnostics market was worth US$ 5.34 Bn and is projected to reach a value of US$ 8.52 Bn by the end of 2031

Home diagnostics market is anticipated to grow at a CAGR of 4.4% during the forecast period

North America accounted for a major share of the global home diagnostics market

Home Diagnostics Market is driven by rise in demand for early disease detection and diagnosis, availability of personalized medicines, growth in prevalence of various lifestyle-associated and infectious diseases

Key players in the global home diagnostics market include SelfDiagnostics, F. Hoffmann-La Roche Ltd., Trinity Biotech Plc, Bionime Corporation, ARKRAY, Inc., ACON Laboratories, Inc., Assure Tech.(Hangzhou) Co., LTD., Abbott, Becton Dickinson & Company, and Quidel Corporation

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Home Diagnostics Market

4. Market Overview

    4.1. Introduction

        4.1.1. Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Home Diagnostics Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Technological Advancements

    5.2. Disease Prevalence & Incidence Rate globally with key countries

    5.3. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)

    5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Home Diagnostics Market Analysis and Forecast, by Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Home Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017–2031

        6.3.1. Glucose Monitoring

        6.3.2. Cholesterol Detection

        6.3.3. Pregnancy

        6.3.4. Allergies & Intolerances

        6.3.5. Infectious Disease Testing

        6.3.6. Fertility, Ovulation, and Sexual Health

        6.3.7. Drug Abuse Testing

    6.4. Global Home Diagnostics Market Attractiveness Analysis, by Type

7. Global Home Diagnostics Market Analysis and Forecast, by Sample Type

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Home Diagnostics Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

        7.3.1. Blood

        7.3.2. Urine

        7.3.3. Others

    7.4. Global Home Diagnostics Market Attractiveness Analysis, by Type

8. Global Home Diagnostics Market Analysis and Forecast, by Distribution Channel

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Global Home Diagnostics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

        8.3.1. Retail

        8.3.2. Online

        8.3.3. Others

    8.4. Global Home Diagnostics Market Attractiveness Analysis, by Distribution Channel

9. Global Home Diagnostics Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Global Home Diagnostics Market Value (US$ Mn) Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Global Home Diagnostics Market Attractiveness Analysis, by Region

10. North America Home Diagnostics Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. North America Home Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017–2031

        10.2.1. Glucose Monitoring

        10.2.2. Cholesterol Detection

        10.2.3. Pregnancy

        10.2.4. Allergies & Intolerances

        10.2.5. Infectious Disease Testing

        10.2.6. Fertility, Ovulation, and Sexual Health

        10.2.7. Drug Abuse Testing

    10.3. North America Home Diagnostics Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

        10.3.1. Blood

        10.3.2. Urine

        10.3.3. Others

    10.4. North America Home Diagnostics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

        10.4.1. Retail

        10.4.2. Online

        10.4.3. Others

    10.5. North America Home Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Market Attractiveness Analysis

        10.6.1. By Type

        10.6.2. By Sample Type

        10.6.3. By Distribution Channel

        10.6.4. By Country

11. Europe Home Diagnostics Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Europe Home Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017–2031

        11.2.1. Glucose Monitoring

        11.2.2. Cholesterol Detection

        11.2.3. Pregnancy

        11.2.4. Allergies & Intolerances

        11.2.5. Infectious Disease Testing

        11.2.6. Fertility, Ovulation, and Sexual Health

        11.2.7. Drug Abuse Testing

    11.3. Europe Home Diagnostics Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

        11.3.1. Blood

        11.3.2. Urine

        11.3.3. Others

    11.4. Europe Home Diagnostics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

        11.4.1. Retail

        11.4.2. Online

        11.4.3. Others

    11.5. Europe Home Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Europe Home Diagnostics Market Attractiveness Analysis

        11.6.1. By Type

        11.6.2. By Sample Type

        11.6.3. By Distribution Channel

        11.6.4. By Country/Sub-region

12. Asia Pacific Home Diagnostics Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Asia Pacific Home Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017–2031

        12.2.1. Glucose Monitoring

        12.2.2. Cholesterol Detection

        12.2.3. Pregnancy

        12.2.4. Allergies & Intolerances

        12.2.5. Infectious Disease Testing

        12.2.6. Fertility, Ovulation, and Sexual Health

        12.2.7. Drug Abuse Testing

    12.3. Asia Pacific Home Diagnostics Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

        12.3.1. Blood

        12.3.2. Urine

        12.3.3. Others

    12.4. Asia Pacific Home Diagnostics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

        12.4.1. Retail

        12.4.2. Online

        12.4.3. Others

    12.5. Asia Pacific Home Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Home Diagnostics Market Attractiveness Analysis

        12.6.1. By Type

        12.6.2. By Sample Type

        12.6.3. By Distribution Channel

        12.6.4. By Country/Sub-region

13. Latin America Home Diagnostics Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Latin America Home Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017–2031

        13.2.1. Glucose Monitoring

        13.2.2. Cholesterol Detection

        13.2.3. Pregnancy

        13.2.4. Allergies & Intolerances

        13.2.5. Infectious Disease Testing

        13.2.6. Fertility, Ovulation, and Sexual Health

        13.2.7. Drug Abuse Testing

    13.3. Latin America Home Diagnostics Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

        13.3.1. Blood

        13.3.2. Urine

        13.3.3. Others

    13.4. Latin America Home Diagnostics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

        13.4.1. Retail

        13.4.2. Online

        13.4.3. Others

    13.5. Latin America Home Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Home Diagnostics Market Attractiveness Analysis

        13.6.1. By Type

        13.6.2. By Sample Type

        13.6.3. By Distribution Channel

        13.6.4. By Country/Sub-region

14. Middle East & Africa Home Diagnostics Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Middle East & Africa Home Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017–2031

        14.2.1. Glucose Monitoring

        14.2.2. Cholesterol Detection

        14.2.3. Pregnancy

        14.2.4. Allergies & Intolerances

        14.2.5. Infectious Disease Testing

        14.2.6. Fertility, Ovulation, and Sexual Health

        14.2.7. Drug Abuse Testing

    14.3. Middle East & Africa Home Diagnostics Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

        14.3.1. Blood

        14.3.2. Urine

        14.3.3. Others

    14.4. Middle East & Africa Home Diagnostics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

        14.4.1. Retail

        14.4.2. Online

        14.4.3. Others

    14.5. Middle East & Africa Home Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa Home Diagnostics Market Attractiveness Analysis

        14.6.1. By Type

        14.6.2. By Sample Type

        14.6.3. By Distribution Channel

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player Competition Matrix (by tier and size of companies)

    15.2. Market Share Analysis, by Company, 2020

    15.3. Company Profiles

        15.3.1. Abbott

            15.3.1.1. Company Overview

            15.3.1.2. Company Financials

            15.3.1.3. Growth Strategies

            15.3.1.4. SWOT Analysis

        15.3.2. ACON Laboratories, Inc.

            15.3.2.1. Company Overview

            15.3.2.2. Company Financials

            15.3.2.3. Growth Strategies

            15.3.2.4. SWOT Analysis

        15.3.3. ARKRAY, Inc.

            15.3.3.1. Company Overview

            15.3.3.2. Company Financials

            15.3.3.3. Growth Strategies

            15.3.3.4. SWOT Analysis

        15.3.4. Assure Tech. (Hangzhou) Co., LTD.

            15.3.4.1. Company Overview

            15.3.4.2. Company Financials

            15.3.4.3. Growth Strategies

            15.3.4.4. SWOT Analysis

        15.3.5. Becton Dickinson & Company

            15.3.5.1. Company Overview

            15.3.5.2. Company Financials

            15.3.5.3. Growth Strategies

            15.3.5.4. SWOT Analysis

        15.3.6. Bionime Corporation

            15.3.6.1. Company Overview

            15.3.6.2. Company Financials

            15.3.6.3. Growth Strategies

            15.3.6.4. SWOT Analysis

        15.3.7. F. Hoffmann-La Roche Ltd.

            15.3.7.1. Company Overview

            15.3.7.2. Company Financials

            15.3.7.3. Growth Strategies

            15.3.7.4. SWOT Analysis

        15.3.8. Quidel Corporation

            15.3.8.1. Company Overview

            15.3.8.2. Company Financials

            15.3.8.3. Growth Strategies

            15.3.8.4. SWOT Analysis

        15.3.9. SelfDiagnostics

            15.3.9.1. Company Overview

            15.3.9.2. Company Financials

            15.3.9.3. Growth Strategies

            15.3.9.4. SWOT Analysis

        15.3.10. Trinity Biotech plc

            15.3.10.1. Company Overview

            15.3.10.2. Company Financials

            15.3.10.3. Growth Strategies

            15.3.10.4. SWOT Analysis

List of Tables

Table 01: Global Home Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 02: Global Home Diagnostics Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 03: Global Home Diagnostics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 04: Global Home Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Home Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Home Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 07: North America Home Diagnostics Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 08: North America Home Diagnostics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 09: Europe Home Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Home Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 11: Europe Home Diagnostics Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 12: Europe Home Diagnostics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 13: Asia Pacific Home Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Home Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 15: Asia Pacific Home Diagnostics Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 16: Asia Pacific Home Diagnostics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 17: Latin America Home Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America Home Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 19: Latin America Home Diagnostics Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 20: Latin America Home Diagnostics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 21: Middle East & Africa Home Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa Home Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 23: Middle East & Africa Home Diagnostics Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 24: Middle East & Africa Home Diagnostics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

List of Figure

Figure 01: Global Home Diagnostics Market Value Share, by Type, 2020

Figure 02: Global Home Diagnostics Market Value Share, by Sample Type, 2020

Figure 03: Global Home Diagnostics Market Value Share, by Distribution Channel, 2020

Figure 04: Global Home Diagnostics Market Value Share, by Region, 2020

Figure 05: Global Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Type, 2020 and 2031

Figure 06: Global Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Type, 2021–2031

Figure 07: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Glucose Monitoring, 2017–2031

Figure 08: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Cholesterol Detection, 2017–2031

Figure 09: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Pregnancy, 2017–2031

Figure 10: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Allergies & Intolerances, 2017–2031

Figure 11: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Urine, 2017–2031

Figure 12: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Fertility, Ovulation & Sexual Health, 2017–2031

Figure 13: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Drug Abuse Testing, 2017–2031

Figure 13: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Drug Abuse Testing, 2017–2031

Figure 14: Global Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 15: Global Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–20

Figure 16: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Blood, 2017–2031

Figure 17: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Urine, 2017–2031

Figure 18: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Others, 2017–2031

Figure 19: Global Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Distribution Channel, 2020 and 2031

Figure 20: Global Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Distribution Channel, 2021–2031

Figure 21: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Retails, 2017–2031

Figure 22: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Online, 2017–2031

Figure 23: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Others, 2017–2031

Figure 24: Global Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Region, 2020 and 2031

Figure 25: Global Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Region, 2021–2031

Figure 26: North America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 27: North America Direct-to-Consumer Laboratory Testing Market Value Share, by Country, 2020 and 2031

Figure 28: North America Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Country, 2021–2031

Figure 29: North America Home Diagnostics Market Value Share Analysis, by Type, 2020 and 2031

Figure 30: North America Home Diagnostics Market Attractiveness Analysis, by Type, 2021–2031

Figure 31: North America Home Diagnostics Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 32: North America Home Diagnostics Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 33: North America Home Diagnostics Market Value Share Analysis, by Distribution Channel, 2020 and 2031

Figure 34: North America Home Diagnostics Market Attractiveness Analysis, by Distribution Channel, 2021–2031

Figure 35: Europe Home Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 36: Europe Home Diagnostics Market Value Share, by Country/Sub-region, 2020 and 2031

Figure 37: Europe Home Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 38: Europe Home Diagnostics Market Value Share Analysis, by Type, 2020 and 2031

Figure 39: Europe Home Diagnostics Market Attractiveness Analysis, by Type, 2021–2031

Figure 40: Europe Home Diagnostics Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 41: Europe Home Diagnostics Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 42: Europe Home Diagnostics Market Value Share Analysis, by Distribution Channel, 2020 and 2031

Figure 43: Europe Home Diagnostics Market Attractiveness Analysis, by Distribution Channel, 2021–2031

Figure 44: Asia Pacific Home Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 45: Asia Pacific Home Diagnostics Market Value Share, by Country/Sub-region, 2020 and 2031

Figure 46: Asia Pacific Home Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 47: Asia Pacific Home Diagnostics Market Value Share Analysis, by Type, 2020 and 2031

Figure 48: Asia Pacific Home Diagnostics Market Attractiveness Analysis, by Type, 2021–2031

Figure 49: Asia Pacific Home Diagnostics Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 50: Asia Pacific Home Diagnostics Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 51: Asia Pacific Home Diagnostics Market Value Share Analysis, by Distribution Channel, 2020 and 2031

Figure 52: Asia Pacific Home Diagnostics Market Attractiveness Analysis, by Distribution Channel, 2021–2031

Figure 53: Latin America Home Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 54: Latin America Home Diagnostics Market Value Share, by Country/Sub-region, 2020 and 2031

Figure 55: Latin America Home Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 56: Latin America Home Diagnostics Market Value Share Analysis, by Type, 2020 and 2031

Figure 57: Latin America Home Diagnostics Market Attractiveness Analysis, by Type, 2021–2031

Figure 58: Latin America Home Diagnostics Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 59: Latin America Home Diagnostics Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 60: Latin America Home Diagnostics Market Value Share Analysis, by Distribution Channel, 2020 and 2031

Figure 61: Latin America Home Diagnostics Market Attractiveness Analysis, by Distribution Channel, 2021–2031

Figure 62: Middle East & Africa Home Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 63: Middle East & Africa Home Diagnostics Market Value Share, by Country/Sub-region, 2020 and 2031

Figure 64: Middle East & Africa Home Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 63: Middle East & Africa Home Diagnostics Market Value Share, by Country/Sub-region, 2020 and 2031

Figure 64: Middle East & Africa Home Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 65: Middle East & Africa Home Diagnostics Market Value Share Analysis, by Type, 2020 and 2031

Figure 66: Middle East & Africa Home Diagnostics Market Attractiveness Analysis, by Type, 2021–2031

Figure 67: Middle East & Africa Home Diagnostics Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 68: Middle East & Africa Home Diagnostics Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 69: Middle East & Africa Home Diagnostics Market Value Share Analysis, by Distribution Channel, 2020 and 2031

Figure 70: Middle East & Africa Home Diagnostics Market Attractiveness Analysis, by Distribution Channel, 2021–2031

Figure 71: Position Analysis, 2020, by Tier and Size of the Company

Figure 72: Breakdown of Net Sales (%), by Business Segment, 2020

Figure 73: Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 74: Breakdown of Net Sales (%), by Business Segment, 2020

Figure 75: Breakdown of Net Sales (%), by Region, 2020

Figure 76: Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Home Diagnostics Market